rs114438816

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018109.4(MTPAP):​c.115G>T​(p.Asp39Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00459 in 1,612,754 control chromosomes in the GnomAD database, including 277 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D39A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.025 ( 145 hom., cov: 28)
Exomes 𝑓: 0.0025 ( 132 hom. )

Consequence

MTPAP
NM_018109.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.547

Publications

3 publications found
Variant links:
Genes affected
MTPAP (HGNC:25532): (mitochondrial poly(A) polymerase) The protein encoded by this gene is a member of the DNA polymerase type-B-like family. This enzyme synthesizes the 3' poly(A) tail of mitochondrial transcripts and plays a role in replication-dependent histone mRNA degradation.[provided by RefSeq, Jan 2011]
MTPAP Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • spastic ataxia 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027908385).
BP6
Variant 10-30349161-C-A is Benign according to our data. Variant chr10-30349161-C-A is described in ClinVar as Benign. ClinVar VariationId is 138279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.084 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTPAPNM_018109.4 linkc.115G>T p.Asp39Tyr missense_variant Exon 1 of 9 ENST00000263063.9 NP_060579.3 Q9NVV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTPAPENST00000263063.9 linkc.115G>T p.Asp39Tyr missense_variant Exon 1 of 9 1 NM_018109.4 ENSP00000263063.3 Q9NVV4-1
MTPAPENST00000421701.1 linkc.1G>T p.Asp1Tyr missense_variant Exon 1 of 3 2 ENSP00000394118.1 Q5T851
MTPAPENST00000488290.5 linkn.1913-7521G>T intron_variant Intron 9 of 16 2
MTPAPENST00000417581.1 linkc.-343G>T upstream_gene_variant 5 ENSP00000404392.1 Q5T852

Frequencies

GnomAD3 genomes
AF:
0.0250
AC:
3781
AN:
151380
Hom.:
145
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0866
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0112
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000280
Gnomad OTH
AF:
0.0130
GnomAD2 exomes
AF:
0.00647
AC:
1624
AN:
251140
AF XY:
0.00466
show subpopulations
Gnomad AFR exome
AF:
0.0888
Gnomad AMR exome
AF:
0.00413
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00310
GnomAD4 exome
AF:
0.00247
AC:
3616
AN:
1461256
Hom.:
132
Cov.:
59
AF XY:
0.00206
AC XY:
1496
AN XY:
726904
show subpopulations
African (AFR)
AF:
0.0892
AC:
2985
AN:
33468
American (AMR)
AF:
0.00499
AC:
223
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53370
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000855
AC:
95
AN:
1111550
Other (OTH)
AF:
0.00492
AC:
297
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
225
451
676
902
1127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0250
AC:
3783
AN:
151498
Hom.:
145
Cov.:
28
AF XY:
0.0240
AC XY:
1776
AN XY:
73982
show subpopulations
African (AFR)
AF:
0.0864
AC:
3567
AN:
41302
American (AMR)
AF:
0.0112
AC:
169
AN:
15130
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5120
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10440
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000280
AC:
19
AN:
67938
Other (OTH)
AF:
0.0129
AC:
27
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
155
310
464
619
774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00932
Hom.:
88
Bravo
AF:
0.0291
ESP6500AA
AF:
0.0831
AC:
366
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00768
AC:
932
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 09, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.033
T;.
Eigen
Benign
-0.045
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.0
N
LIST_S2
Benign
0.52
T;D
MetaRNN
Benign
0.0018
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;.
PhyloP100
0.55
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.86
N;D
REVEL
Benign
0.065
Sift
Benign
0.039
D;D
Sift4G
Benign
0.066
T;D
Polyphen
0.94
P;D
Vest4
0.43
MVP
0.37
MPC
0.55
ClinPred
0.015
T
GERP RS
3.3
PromoterAI
-0.096
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.077
gMVP
0.44
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114438816; hg19: chr10-30638090; API